Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Optimizing your budget with zero-based techniques can significantly improve cash flow. Explore methods that work for you.
23,484 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
The stock market often rides policy signals as much as earnings. This piece digs into two decision scenarios that cou...
A realized gain of $40,000 in 2025 could push 2027 Medicare costs higher for some retirees due to the two-year lookba...
Two energy infrastructure ETFs are under the lens as crude markets stay volatile. EMLP and ENFR continue payouts, but...
Nancy Pelosi disclosed a multi-million-dollar stake in AllianceBernstein units, signaling diversification into steady...
Bit Digital faces shifting crypto markets. This guide breaks down what to watch in the Q1 2026 earnings transcript an...
SpaceX grabs headlines, but a smaller IPO could offer bigger upside for patient investors. This guide walks you throu...
Usio's Q4 2025 earnings reveal a business building momentum in payments services. This analysis breaks down the numbe...
Alphabet surged over the past year, but a 10% pullback from its high has investors wondering if now is the moment to ...
In 2026, Marvell Technology has become a focal point for investors. This article breaks down the drivers behind the r...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
As we reach the halfway point of 2026, certain S&P 500 members are leading the pack with impressive gains. This artic...